Monthly Archives: May 2017

Ruxolitinib for the Treatment of Portal Hypertension in a Patient With Primary Myelofibrosis

Posted on May 4, 2017 by Gastroenterology Journal

Primary myelofibrosis is a form of myeloproliferative neoplasm characterized by stem-cell derived clonal proliferation, resulting in bone marrow fibrosis, splenomegaly and extramedullary haematopoiesis, with portal hypertension (PHT) occuring in 10%–… Continue reading →

Posted in News | Comments Off on Ruxolitinib for the Treatment of Portal Hypertension in a Patient With Primary Myelofibrosis

Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic Patients by Modulating Blood–Brain Barrier Drug Transport

Posted on May 4, 2017 by Gastroenterology Journal

We read with interest the article by Tsai et al1 in a recent issue of Gastroenterology, which highlights the influence of proton pump inhibitors (PPIs) use on encephalopathy occurrence in cirrhotic patients. This case control study performed in a larg… Continue reading →

Posted in News | Comments Off on Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic Patients by Modulating Blood–Brain Barrier Drug Transport

Covering the Cover

Posted on May 3, 2017 by Andrew T. Chan, Christopher S. Williams

In a small study of patients with esophagitis or Barrett’s esophagus, a weight-lifter belt increased postprandial gastroesophageal reflux. Continue reading →

Posted in News | Comments Off on Covering the Cover

Atlas of Esophageal Disease and Intervention: A Multidisciplinary Approach

Posted on May 3, 2017 by Gastroenterology Journal

I read with great interest this hardback book, which is compiled as an atlas of esophageal diseases. The authors should be congratulated for a very nice product, which I am sure will serve as a resource to many interested in better understanding of eso… Continue reading →

Posted in News | Comments Off on Atlas of Esophageal Disease and Intervention: A Multidisciplinary Approach

Early Detection of Hepatocellular Carcinoma after Treatment With Direct-Acting Antivirals: Selection Bias or Biologically Plausible?

Posted on May 3, 2017 by Gastroenterology Journal

Conti F, Buonfiglioli F, Scuteri A, et al. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J Hepatol 2016;65(4):727-733. Continue reading →

Posted in News | Comments Off on Early Detection of Hepatocellular Carcinoma after Treatment With Direct-Acting Antivirals: Selection Bias or Biologically Plausible?